Industry 4.0 requires comprehensive data collection in order to control highly automated process sequences in complex production environments. One example is the cultivation of living cells. But digitalizing and networking biotech production equipment is a huge challenge: relevant standards have yet to be established, and biology has a dynamic all its own.
Using fully automated equipment for producing stem cells, Fraunhofer researchers have managed to adjust the process control to cell growth – delivering an adaptive system that is suitable for use in a number of sectors.
Industry 4.0 requires comprehensive data collection in order to control highly automated process sequences in complex production environments. One example is the cultivation of living cells. But digitalizing and networking biotech production equipment is a huge challenge: relevant standards have yet to be established, and biology has a dynamic all its own. Using fully automated equipment for producing stem cells, Fraunhofer researchers have managed to adjust the process control to cell growth – delivering an adaptive system that is suitable for use in a number of sectors.
The term industry 4.0 is generally associated with the manufacturing of cars, machinery or industrial goods. But, as the partners (see box) in the StemCellFactory collaborative project show, the comprehensive networking of machines and products is also making headway in biotechnology. This is a particular challenge, because this field deals not with solid components but with living objects that – unlike screws or gears – change and multiply. Networked process control needs to take this into account and be able to adjust the process accordingly in real time.
The StemCellFactory project partners have set up a fully automated production line for culturing stem cells, which can develop into any kind of cell found in the body; experts call them induced pluripotent stem cells (iPS cells). Researchers from the Fraunhofer Institute for Production Technology IPT will be presenting the production line at the Hannover Messe Preview on January 27 and at the Hannover Messe (Hall 17, Booth C18 and Hall 2, Booth C16) from April 25 to 29. Medical expertise was provided by experts from the university clinics in Bonn and Aachen, among others. iPS cells such as these are necessary in the development of medications used in personalized medicine. They are obtained from adult body cells such as human skin or blood cells. First, a doctor takes cells from a patient. Next, these cells are reprogrammed to become iPS cells by adding certain substances. This causes the cells to revert to an embryonic state, from which they can theoretically differentiate into any cell type – even heart or nerve cells, which, owing to the risk to the patient, cannot be obtained by means of a biopsy. The pharmaceutical industry uses these cells for medical tests: since they contain the patient’s own genetic information, the cells are very useful for determining which medications will be effective.
Fully automated, modular production platform
To date, iPS cells are grown by lab specialists in a painstaking, time-consuming process. The number and quality of iPS cells that can be cultured depend entirely on how experienced the lab technician is. This is why the project aimed to develop fully automated, modular equipment that achieves both a high throughput and a consistently high quality of stem cells. The IPT experts were given the task of developing both the equipment and its control mechanisms. They faced a number of challenges, the first being how to network the various biotech devices – liquid handling robot, a microscope, an incubator, and the automatic magazine for storing cells and containers – in a way that permitted the use of process-control technology in the first place. “Despite the industry’s efforts to establish uniform interfaces for lab automation equipment, there is as yet no international standard for networking the devices used,” says IPT developer Michael Kulik. “That means plug and play is not an option, so we first had to develop a standard of our own before we could integrate everything.”
This approach achieved a very high degree of networking in order to allow the process-control technology and the lab equipment to exchange information. That in turn was the prerequisite for the equipment to adjust extremely flexibly to the biological processes at work. Cell growth is the decisive factor. As the cells grow in the cell culture vessels, they divide again and again. To ensure conditions don’t get too cramped for the cells, from time to time the pipette feeder robot has to distribute them among a larger number of fresh, empty cell culture vessels.
To this end, the microscope developed at the IPT regularly examines the growth density inside the cell culture vessels. Once a critical density is reached, the microscope sends out an instruction to rehouse the cells. “This is an example of the product, in this case the growing stem cells, determining how the overall process unfolds,” says Kulik. In other words: production has the capability to adjust itself to the present situation.
A user interface makes it easy to control each device included in the equipment. If the user needs to alter or add to the equipment’s process steps, there are pre-programmed blocks of instructions that they can simply drag into or out of the control menu. Staff can choose whether to operate the equipment in fully automated or manual mode.
The technology developed as part of the StemCellFactory project can also be applied in other situations, for instance in tissue engineering and the production of tissue models. It would also be possible to use it to manufacture gears, screws, engines, etc. in a fully automated way. The software is scalable, making it suitable for small and large production facilities alike. Since the programming is extremely flexible, the process-control technology can be transferred to any other production setup in need of adaptive control on the basis of current measurement data. During the Hannover Messe, visitors will be treated to a live demonstration of how the StemCellFactory is controlled remotely, specifically from Bonn.
Read more: Adjusting production processes in real time
The Latest on: Industry 4.0
via Google News
The Latest on: Industry 4.0
- Versatility key to Vanguard embracing Industry 4.0 on April 18, 2019 at 5:49 pm
The heavy lifting and abnormal loads sector has embraced Industry 4.0 and incorporated many new technologies, such as three-dimensional (3D) modelling of heavy lift solutions and real-time data ... […]
- Academy launched to align learners with Industry 4.0 on April 18, 2019 at 4:21 pm
Competency-based training institute Polytech Africa and industrial switchgear and automation management supplier ElectroMechanica (EM) launched the Mechatronics Academy, at the EM head office, in ... […]
- Dicyclopentadiene (DCPD) Market in the advanced material industry is Likely to Reach 4.0% CAGR in 2021 on April 18, 2019 at 3:02 pm
Launching announcement of a new research report on Dicyclopentadiene (DCPD) Market which is projected to reach 4.0% CAGR by 2021 - forecasted by Stratview Research. The study provides an in-depth by ... […]
- Manufactured Perceptions: Why Industry Needs To Reset Its Reputation on April 18, 2019 at 12:46 pm
The impact of technology on manufacturing is in the early stage of another giant leap, as Industry 4.0 emerges. While things like automation, robotics and industrial process technologies have already ... […]
- Italeaf: Softeco, digital company of TerniEnergia Group, in the Zero Defects Manufacturing Platform (ZDMP) project for industry 4.0 on April 18, 2019 at 5:36 am
TerniEnergia, a smart company listed on the Italian Stock Exchange's electronic share market (MTA) and part of the Italeaf Group, Softeco Sismat Srl, the Group's digital company, and Zero Defect ... […]
- Hermle to Highlight Automation and Industry 4.0 at Annual Open House on April 17, 2019 at 12:23 pm
Hermle AG is planning on welcoming over 1,000 companies and 3,000 visitors from across the globe to its annual Global Open House event in Gosheim, Germany, May 8-11, 2019. Visitors will have the ... […]
- How Industry 4.0 Can Improve Customer Experience From Design To Operation on April 15, 2019 at 5:12 am
Industry 4.0 is often equated with the idea of the smart factory. Manufacturers, it is said, can use intelligent technologies to automate and optimize the shop floor – thus producing more at lower ... […]
- INDUSTRY 4.0 Michigan Manufacturers Share Their Automation Journey on April 14, 2019 at 8:08 pm
The manufacturing industry is rapidly approaching a place where only those companies that have implemented automation and robotic equipment will survive. With recent improvements to modularity, ... […]
- Only 5% of Mid-Size Manufacturers Are Implementing Industry 4.0 on April 12, 2019 at 5:26 am
Mid-market manufacturers are struggling to implement Industry 4.0 technology even as it beocmes a comeptitive factor. (Image source: BDO) While major manufacturers have been hip-deep in Industry 4.0 ... […]
- Industry 4.0 Market Share, Size, by Top Key Players Analysis Beijer Electronics Ab, Worldsensing, Sri International, Cyberx and Among others on April 11, 2019 at 6:26 am
Apr 11, 2019 (Heraldkeeper via COMTEX) -- Industry 4.0 Market report is source of key information about the Market, including invaluable facts and figures, expert opinions, and the latest developments ... […]
via Bing News